This page uses content from Wikipedia and is licensed under CC BY-SA.

Phendimetrazine

Phendimetrazine
Phendimetrazine.svg
Clinical data
Trade namesBontril
AHFS/Drugs.comMonograph
Pregnancy
category
  • C (US)
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
Pharmacokinetic data
BioavailabilityPeak plasma levels occur within 1 to 3 hours. Absorption is usually complete by 4 to 6 hours
MetabolismHepatic
Elimination half-life19-24 hours
ExcretionUrinary elimination
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.010.186 Edit this at Wikidata
Chemical and physical data
FormulaC12H17NO
Molar mass191.27 g/mol g·mol−1
3D model (JSmol)
  (verify)

Phendimetrazine (Bontril, Adipost, Anorex-SR, Appecon, Melfiat, Obezine, Phendiet, Plegine, Prelu-2, Statobex) is a stimulant drug of the morpholine chemical class used as an appetite suppressant.[1]

Pharmacology

Phendimetrazine functions as a prodrug to phenmetrazine; approximately 30 percent of an oral dose is converted into it. Phendimetrazine can essentially be thought of as an extended-release formulation of phenmetrazine with less potential for abuse. Phenmetrazine acts as a norepinephrine-dopamine releasing agent (NDRA).[2]

Its structure incorporates the backbone of methamphetamine, a potent CNS stimulant. While the addition of an N-methyl group to amphetamine significantly increases its potency and bioavailability, methylation of phendimetrazine renders the compound virtually inactive. Metabolization by demethylases produces a steady, continuous activation of the drug in the body, both lowering abuse potential and allowing for once-daily administration.[citation needed]

Legality

According to the List of Psychotropic Substances under International Control published by the International Narcotics Control Board, phendimetrazine is a Schedule III controlled substance under the Convention on Psychotropic Substances.[3]

See also

Phendimetrazine.jpg

References

  1. ^ Landau D, Jackson J, Gonzalez G (2008). "A case of demand ischemia from phendimetrazine". Cases J. 1 (1): 105. doi:10.1186/1757-1626-1-105. PMC 2531092. PMID 18710555.
  2. ^ Rothman RB, Baumann MH (2006). "Therapeutic potential of monoamine transporter substrates". Current Topics in Medicinal Chemistry. 6 (17): 1845–59. doi:10.2174/156802606778249766. PMID 17017961.
  3. ^ List of psychotropic substances under international control